EH
TNXP icon

Equitable Holdings’s Tonix Pharmaceuticals TNXP Stock Holding History

Equitable Holdings’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,525
Closed -$379K – 1590
2025
Q2 		$379K Sell
10,525
-4,475
-30% -$117K ﹤0.01% 1108
2025
Q1 		$268K Buy
+15,000
New +$304K ﹤0.01% 1136
2022
Q2 		– Hold
0
– -$5K – 920
2022
Q1 		– Hold
0
– – – 867
2021
Q4 		– Hold
0
– – – 851
2021
Q3 		– Hold
0
– – – 828
2021
Q2 		– Hold
0
– – – 811
2021
Q1 		– Hold
0
– – – 744
2020
Q4 		– Hold
0
– – – 678
2020
Q3 		– Hold
0
– – – 621
2020
Q2 		– Hold
0
– – – 622

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SPS
Susquehanna Portfolio Strategies Bala Cynwyd, Pennsylvania $6.73B AUM 45.57% 1-Year Est. Return

Equitable Holdings's TNXP Position: Q3 2025 in Review

Equitable Holdings sold out of Tonix Pharmaceuticals (TNXP) in Q3 2025, closing a stake of 10,525 shares — an estimated $379K sold.

Equitable Holdings first reported a position in TNXP in Q1 2025 and held it in 2 quarters. The position peaked at $379K in Q2 2025. 60 funds tracked by Wall St. Rank hold TNXP as of Q3 2025.

  • Equitable Holdings reported no remaining Tonix Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Equitable Holdings sold 10,525 Tonix Pharmaceuticals shares in Q3 2025, an estimated $379K.
  • Equitable Holdings first reported a position in Tonix Pharmaceuticals in Q1 2025 and held it in 2 quarters.
  • Equitable Holdings's Tonix Pharmaceuticals position peaked at $379K in Q2 2025.
  • 60 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q3 2025.

Based on Equitable Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.